Show simple item record

dc.contributor.authorKekare, Ashish
dc.date.accessioned2014-07-18T13:31:23Z
dc.date.available2014-07-18T13:31:23Z
dc.date.issued2013
dc.identifier.issn1309-0801
dc.identifier.urihttp://dspace.marmara.edu.tr/handle/18832014/1481
dc.description.abstractThere are 27 European Union (EU) member states, 3 European Economic Area (EEA) and European Free Trade Association (EFTA) states. For a company willing to market the medicinal product in to the EEA, marketing authorization (MA) for the respective product must be issued by competent authority of member state or authorization granted according to Regulation (EC) No. 726/2004 for entire community. Europe constitutes large population and European government is alert regarding safety of the public in EU. There are changes in the procedures for the marketing authorization by the EU. Different types of procedures for the application of marketing authorization are available in the EU and these procedures are discussed here.en_US
dc.language.isoenen_US
dc.publisherMarmara Pharmaceutical Journalen_US
dc.subjectEuropean Economic Area, marketing authorization.en_US
dc.titleDrug product registration and marketing authorization procedures in EU-A perspectiveen_US
dc.typeArticleen_US
dc.contributor.authorID


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record